相关实验视频

Updated: Jul 3, 2025

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

结合抗生素与抗TLR2/TLR13治疗,可以预防肺炎球菌脑膜炎的脑病变

Susanne Dyckhoff-Shen¹, Ilias Masouris¹, Heba Islam²

¹Department of Neurology, LMU University Hospital, LMU Munich, Germany.

|February 15, 2024

概括

通过抗体和氨酸阻断托尔类受体 (TLRs) 2和13显著改善了肺炎球菌脑膜炎的结果. 这种TLR阻塞为抗生素治疗提供了一个有希望的补充剂,用于减少大脑炎症.

科学领域:

免疫学免疫学免疫学
传染性疾病传染性疾病
神经科学是一个神经科学.

背景情况:

肺炎球菌脑膜炎导致严重的大脑炎症,尽管抗生素治疗.
髓分化主响应适配器88 (MyD88) 路径的激活在脑膜炎病理学中至关重要.
收费类受体 (TLRs) 2和13是Streptococcus pneumoniae的关键传感器.

研究的目的:

研究TLR2和TLR13在肺炎球菌脑膜炎中的作用.
评估阻断TLR2和TLR13的治疗潜力.

主要方法:

在Myd88-/-, Tlr2-/- Tlr13-/-小鼠中对疾病进展的比较分析.
使用抗TLR2抗体 (T2.5) 和 (CQ) 抑制TLR2和TLR13.
在小鼠肺炎球菌脑膜炎模型中评估免疫细胞激活和临床结果.

主要成果:

确定TLR2和TLR13是脑脊液中S. pneumoniae的主传感器.
这种T2.5/CQ尾酒有效地废除了由S. pneumoniae.引起的免疫细胞激活.
与 ceftriaxone 结合的 TLR2/TLR13 阻断比德克萨米他更能改善脑膜炎的临床过程.

结论:

鼠TLR13和人类TLR8,以及TLR2,在肺炎球菌脑膜炎中起着重要的作用.
阻断TLR2和TLR13是一种有前途的抗生素辅助疗法,用于肺炎球菌脑膜炎.

关键词:

细菌感染细菌感染细胞免疫反应的细胞免疫反应.传染病传染病传染病传染病这是天生的免疫力.

更多相关视频

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

相关概念视频

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Defense Against Bacterial Pathogens

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: